Home › Hansa Medical develops second-generation IdeS molecules for repeat dosing
 

Keywords :   


Hansa Medical develops second-generation IdeS molecules for repeat dosing

2015-02-12 14:11:05| Appliances - Topix.net

Hansa Medical AB announced today that the company is developing a new generation of molecules based on IdeS that will allow repeat dosing and thereby broadening the therapeutic opportunities into more chronic disease areas. Since IdeS is a bacterial protein from Group A streptococcus the human immune system recognizes IdeS as foreign and reacts against the molecule.

Tags: medical repeat develops molecules

Category:Consumer Goods and Services

Latest from this category

All news
17.05Johnson & Johnson Acquires Atopic Dermatitis Treatment Biotech Company
17.05Register For Sustainable Cosmetics Summit
17.05Fewer crackers in Ritz boxes but price remains same
17.05Boeing boss's $33m pay package approved
17.05Urban Decay Renews Sponsorship Agreement with the Los Angeles Sparks
17.05Bank of England plans expansion of Leeds base
17.05Bank of England plans expansion of Leeds base
17.05Henkel Laundry Patent Details Transfer of Encapsulated Fragrance with Dryer Balls
Consumer Goods and Services »
17.05Johnson & Johnson Acquires Atopic Dermatitis Treatment Biotech Company
17.05Register For Sustainable Cosmetics Summit
17.05Fewer crackers in Ritz boxes but price remains same
17.05Eastern North Pacific Tropical Weather Outlook
17.05Boeing boss's $33m pay package approved
17.05Heifers and female cows remain hot topic at sale barn
17.05Dutch Boy Paints Introduces Professional Series at Menards
17.05Atlantic Tropical Weather Outlook
More »